Gene · 4986
Papers4,507
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,507
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users. | Clin Transl Sci | 2022 | 34708917 | PubTator, text mining | PubMed |
| The Mid-Life Dip in Well-Being: a Critique. | Soc Indic Res | 2022 | 34690403 | PubTator, text mining | PubMed |
| Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours. | Neuropsychopharmacology | 2022 | 34663867 | PubTator, text mining | PubMed |
| Effect of cold and heat therapies on pain relief in patients with delayed onset muscle soreness: A network meta-analysis. | J Rehabil Med | 2022 | 34636405 | PubTator, text mining | PubMed |
| Early Neurorehabilitation and Recovery from Disorders of Consciousness After Severe COVID-19. | Neurocrit Care | 2022 | 34611810 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the MicroRNA-Metabolic Gene Regulatory Network in Neuropathic Pain and Prediction of Corresponding Potential Therapeutics. | J Mol Neurosci | 2022 | 34580818 | PubTator, text mining | PubMed |
| The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A. | Int J Neuropsychopharmacol | 2022 | 34537829 | PubTator, text mining | PubMed |
| The Comprehensive Neural Mechanism of Oxytocin in Analgesia. | Curr Neuropharmacol | 2022 | 34525934 | PubTator, text mining | PubMed |
| Novel selective κ agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion. | Acta Pharmacol Sin | 2022 | 34493813 | PubTator, text mining | PubMed |
| Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development. | Handb Exp Pharmacol | 2022 | 34463847 | PubTator, text mining | PubMed |
| Molecular genetics of cocaine use disorders in humans. | Mol Psychiatry | 2022 | 34453125 | PubTator, text mining | PubMed |
| Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography. | Handb Exp Pharmacol | 2022 | 34363128 | PubTator, text mining | PubMed |
| The Interplay between Chronic Pain, Opioids, and the Immune System. | Neuroscientist | 2022 | 34269117 | PubTator, text mining | PubMed |
| Obesity and dietary fat influence dopamine neurotransmission: exploring the convergence of metabolic state, physiological stress, and inflammation on dopaminergic control of food intake. | Nutr Res Rev | 2022 | 34184629 | PubTator, text mining | PubMed |
| Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder. | Handb Exp Pharmacol | 2022 | 34136961 | PubTator, text mining | PubMed |
| Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial. | Addiction | 2022 | 34105213 | PubTator, text mining | PubMed |
| Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System. | Handb Exp Pharmacol | 2022 | 34085120 | PubTator, text mining | PubMed |
| Structural Characterization of KOR Inactive and Active States for 3D Pharmacology and Drug Discovery. | Handb Exp Pharmacol | 2022 | 33945028 | PubTator, text mining | PubMed |
| Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist. | Handb Exp Pharmacol | 2022 | 33834276 | PubTator, text mining | PubMed |
| Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function. | Handb Exp Pharmacol | 2022 | 33754230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4986/papers?page=53